You started finasteride to fix your hairline. Nobody warned you it might mess with something else entirely. Now you are lying awake wondering: can topical finasteride cause erectile dysfunction or is that only a pill problem?
You are not overreacting and you are not alone. Reported rates vary considerably depending on the study, the dose, and whether ED is measured alone or combined with other sexual side effects from roughly 1% to 5% in large trials to over 40% in smaller studies where patients were told about the possible side effect in advance.
This guide breaks down exactly what the data says about finasteride erectile dysfunction, how common erectile dysfunction is with finasteride across oral and topical forms and what finasteride erectile dysfunction recovery actually looks like written specifically for men trying to make an informed decision about their hair loss treatment and their sexual health.
What Are the Sexual Side Effects of Finasteride?
Finasteride is classified as an inhibitor of 5-alpha reductase. The medication works by blocking the conversion of testosterone into a hormone called dihydrotestosterone (DHT), responsible for hair loss in men. DHT is also involved in the sexual mechanisms of the human body, which means that lowering the levels of this hormone has effects other than those concerning hair loss (GoodRx).
The complete list of sexual side effects of finasteride includes:
- Erectile dysfunction – difficulties with having or maintaining an erection.
- Low libido– decreased physiological or psychological interest in having sexual intercourse.
- Ejaculatory disorders – low volume of ejaculate, delayed ejaculation and weakened orgasm.
- Low degree of arousal – decreased bodily and mental responses to sexual stimuli.
- Lack of morning or spontaneous erections – reported by as many as 89% of men suffering from long-term side effects.
- Low sperm count – a less discussed problem that can influence fertility during medication use.
- Changes in penile sensitivity – some men experience decreased sensitivity of their genitals and report it in studies.
These effects have been reported with both the 1mg dosage used for hair loss (Propecia) and the 5mg dosage used for enlarged prostate (Proscar). The two doses are typically studied in different populations (younger men for hair loss, older men with prostate symptoms), so direct comparisons of incidence between them are unreliable.
Sexual Side Effects by the Numbers
Sexual Side Effect | Reported Incidence | Source |
Erectile dysfunction, uninformed vs. informed patients (5mg, prostate) | 9.6% vs. 30.9% | Mondaini et al., 2007 |
Any sexual adverse effect (pooled meta-analysis, 1mg) | 5.31% vs. 3.05% placebo | Acta Derm-Venereol meta-analysis |
ED among men who already reported persistent symptoms (small self-selected sample, n=71) | 92% | Irwig & Kolukula, 2011 |
Low libido among men with persistent side effects | 94% | Irwig & Kolukula, 2011 |
Loss of morning erections (persistent cases) | 89% | Ganzer & Jacobs, 2016 |
New-onset ED, large young-male cohort | 1.4% finasteride vs. 0.9% placebo | Systematic review, 1,553 men |
How Common Is Erectile Dysfunction With Finasteride?
The answer is quite uncertain as it relies greatly on the study being read which patients were aware of the possible side effect. A landmark 2007 study of men taking 5 mg finasteride for an enlarged prostate (not the typical 1mg hair loss dose) found that patient expectations affected reported outcomes. Men who were informed in advance about possible sexual side effects reported erectile dysfunction specifically at a rate of 30.9% compared to 9.6% among men who were not informed. Rates of any sexual side effect (a broader measure) were higher still, 43.6% versus 15.3% respectively. This gap is known as the nocebo effect where negative expectations can influence how symptoms are experienced and reported.
When taking into account the nocebo effect, a pooled analysis of 11 studies demonstrates that the finasteride 1mg/day almost doubles the chances of patients developing erectile dysfunction in comparison with placebo.
Does Finasteride 1mg Cause Erectile Dysfunction?
Yes, finasteride 1mg is associated with erectile dysfunction. In a large study of 1,553 men aged 18–41 taking the 1mg dose, 1.4% reported ED compared with 0.9% on placebo.
An analysis that observed 1,553 men aged 18 to 41 years revealed that 1.4% of the men administered with Finasteride reported erectile dysfunction as opposed to 0.9% of those placed on placebo treatment, thus proving that there exists a slight difference with regards to the drug's side effects.
Does Finasteride Always Cause Erectile Dysfunction?
No. There is a common misconception that Finasteride always results in erectile dysfunction. Majority of men, between 85 and 95% depending on the research conducted, do not seem to experience any sexual problems, although those who do seem to present with mild side effects that are resolved with time.
Persistent sexual symptoms (sometimes called post-finasteride syndrome) have been reported. Their true frequency is uncertain, since the evidence comes mainly from case series rather than randomized trials a study design that can describe cases but can't establish how common they actually are.
Can Topical Finasteride Cause Erectile Dysfunction?
This is an important question that many men ask when switching to the topical form of finasteride. The answer is yes, topical finasteride can lead to erectile problems, but one 24-week trial reported numerically fewer combined sexual adverse events with the tested topical formulation than with oral finasteride. This finding is specific to that formulation and study, and shouldn't be read as proof that every topical or compounded finasteride product carries a lower ED risk.
In a mid-2021 study, 0.25% topical finasteride spray was tested against placebo and oral finasteride. Combined sexual adverse events (covering erectile dysfunction, decreased libido and sexual dysfunction together, not ED alone) were reported in 2.8% of topical users compared with 3.3% on placebo and 4.8% on oral finasteride which means the topical group's rate was close to placebo.
The likely reason: blood absorption. The same study measured finasteride blood concentration after 6 months and found:
Formulation | Average Blood Concentration |
Topical finasteride spray (0.25%) | 48.0 ± 87.2 pg/mL |
Oral finasteride tablet (1mg) | 5,029 ± 4,182 pg/mL |
This indicates approximately 100 times less systemic exposure thanks to the topical spray. It is worth noting that lower blood concentration does not mean proportionally lower biological effect: the same study found serum DHT suppression of approximately 35% with topical use compared to approximately 56% with oral use, a meaningful reduction, but not the dramatic difference the blood concentration numbers alone might suggest. In a study conducted by an independent laboratory, it was found that XYON's proprietary Siloxys gel corresponds to 92% less drug absorption in the bloodstream when applied as compared to the oral form of the medication (in one manufacturer's product-specific test, not a general topical finasteride benchmark).
This issue is crucial because sexual side effects arise from the systemic suppression of DHT in the entire organism, rather than in the scalp only. Lower systemic drug levels are associated with a lower likelihood of interfering with erectile function though this has not been established as a fixed or universal ratio and findings from one formulation should not be assumed to apply to all compounded topical products.
Does Finasteride Spray Cause Erectile Dysfunction?
Yes, it is possible, although researchers indicate this is rare. The same 2021 clinical trial examined the effect of finasteride spray on erectile dysfunction directly and found no differences in sexual dysfunction scores between the control and experimental groups.
It should be pointed out that topical finasteride, regardless of its type spray, gel or solution is not approved by the FDA. It is a compounded drug, which means its exact strength and absorption may differ from pharmacy to pharmacy and preparation to preparation.
Oral vs. Topical Finasteride: Sexual Side Effect Comparison
Factor | Oral Finasteride (1mg) | Topical Finasteride |
FDA approval | Approved for hair loss | Not FDA approved (compounded) |
Combined sexual adverse event rate (24-week trial) | 4.8% | 2.8% (placebo: 3.3%) |
Systemic blood concentration | Approx. 5,029 pg/mL (avg.) | Around 48 pg/mL (avg.) — Around 100x lower |
Local side effects | Rare | More common (scalp irritation, itching, redness) |
Best suited for | Men prioritizing convenience | Men prioritizing lower systemic risk |
Dutasteride vs Finasteride: Which Has a Higher Erectile Dysfunction Risk?
Dutasteride is a related 5-alpha-reductase inhibitor that is sometimes prescribed off-label for hair loss, especially when finasteride does not work well enough. The verdict on dutasteride vs finasteride erectile dysfunction in terms of ED risk remains controversial. However, there is a tendency to think that dutasteride might have similar or slightly greater sexual side effects, though the evidence on its ED risk remains inconclusive.
Factor | Finasteride (1mg) | Dutasteride (0.5mg) |
DHT suppression | Suppresses ~70% | Suppresses ~90%+ (more potent) |
Any adverse sexual effect (pooled) | 5.31% | Slightly higher, not statistically significant in most pooled data |
Erectile dysfunction specifically | Nearly 2x placebo risk | Minimal difference from placebo in most pooled analyses |
Half-life | 5–6 hours | ~5 weeks (much longer) |
Duration of side effects if they occur | Not established for either drug | Not established, longer clearance time doesn't confirm longer symptoms |
Importantly, the difference between the two lies in the fact that dutasteride has a much higher half-life. Dutasteride clears from the body more slowly than finasteride, but whether this actually translates into longer-lasting side effects has not been directly established in comparative studies. (Acta Dermato-Venereologica).
Finasteride Erectile Dysfunction Recovery: What to Expect
For many men, sexual side effects improve either while still taking finasteride or after stopping, but recovery is not guaranteed for everyone, and a recognised subset of men report symptoms that persist well beyond drug clearance. In the PLESS trial, among men who discontinued treatment specifically because of a sexual adverse event, 50% of those on finasteride and 41% of those on placebo reported resolution of the symptom after stopping. This trial does not establish a specific recovery timeframe, and the similar rates between groups should not be read as proof of a particular mechanism behind recovery only that resolution occurred in both groups.
Recovery timelines reported across studies:
Scenario | Typical Recovery Pattern |
Mild ED while continuing finasteride | Some men report improvement over time, though this hasn't been established in controlled studies with a defined timeframe |
ED after stopping finasteride | Varies by individual, some men see improvement within weeks but drug clearance (about a day) does not guarantee symptom resolution on the same timeline |
Persistent sexual side effects (PFS) | Typical duration isn't well established; one small case-series study of self selected participants reported symptoms averaging around 40 months, with about 20% still symptomatic after 6+ years, these figures ca not be generalized into a reliable recovery timeline |
At the present moment, there are no treatments for post-finasteride syndrome approved by doctors. The treatment is aimed at eliminating separate symptoms: ED medications, therapy for emotional symptoms and lifestyle changes, under the supervision of a doctor.
Frequently Asked Questions
Can topical finasteride cause erectile dysfunction?
In one 24 week trial, topical finasteride was linked to a combined sexual adverse event rate of about 2.8%, versus 4.8% for oral users and 3.3% for placebo with the topical rate close to placebo. This is likely related to markedly lower blood concentrations with topical use, though this finding is specific to that formulation and study and blood levels don't necessarily translate directly into a proportional drop in risk for all compounded topical products.
How common is erectile dysfunction with finasteride?
According to various studies, large trials generally put new-onset ED at around 1% to 5%, though the specific figure depends heavily on dose, study design and whether patients were told about the possible side effect beforehand. Meta-analyses indicate that the actual prevalence may be twice that of placebo medication.
Does finasteride 1mg cause erectile dysfunction?
Yes, in a large study of 1,553 men aged 18–41 taking the 1mg dose, 1.4% reported ED compared with 0.9% on placebo. The 1mg (hair loss) and 5mg (prostate) doses are typically studied in different age groups and populations, so direct comparisons of incidence between the two doses are unreliable
Does finasteride always cause erectile dysfunction?
No, since the majority of men do not have any negative sexual side effects while taking finasteride — the reported number is estimated to be about 85% to 95%.
How long does it take to recover from finasteride-related ED?
Recovery time varies. While finasteride clears from the body within about a day, this does not mean symptoms resolve on the same timeline some men see improvement within weeks of stopping while a smaller number experience prolonged sexual side effects lasting months or years.
Is dutasteride safer than finasteride for erectile dysfunction?
Not necessarily. Dutasteride suppresses DHT more aggressively and clears from the body much more slowly, but whether this actually results in longer-lasting side effects hasn't been directly established in comparative studies. The specific ED risk between the two drugs appears similar in most pooled data.
